intellim Holdings Corporation would like to inform you that we assumed the capital increase implemented by intellim Corporation.

1.Background

Our group company, intellim Corporation has been providing total solutions from drug development to clinical development as a clinical trial partner with the vision of “Being a No. 1 Clinical Development Partner in Asia”. intellim Corporation has put all its energy into exercising the best performance and provided solutions to clients since its establishment. As the result, intellim Corporation became a fast-growing company providing high quality services as an independent CRO in Japan.

In recent years, demand for R&D outsourcing both from domestic and overseas clients has been on the rise, and the needs of clients has diversified rapidly. In response to this change, intellim has implemented a capital increase to further strengthen its management base, expand service offerings in a push forward. The capital of intellim Corporation has been increased to one hundred million yen.

Our group will continue to expand its services to meet clients’ needs.

2.Corporate profile